SOPHiA GENETICS SA. (NASDAQ:SOPH) Q1 2025 Earnings Conference Call May 6, 2025 8:00 AM ET
Company Participants
Kellen Sanger – Head, Strategy and Investor Relations
Jurgi Camblong – Co-Founder and Chief Executive Officer
Ross Muken – President
George Cardoza – Chief Financial Officer
Conference Call Participants
William Bonello – Craig-Hallum
Conor McNamara – RBC Capital Markets
Subbu Nambi – Guggenheim
Operator
Good morning, ladies and gentlemen, and welcome to the SOPHiA GENETICS Q1 2025 Earnings Call. [Operator Instructions]. This call is being recorded on Tuesday, May 6, 2025.
I would now like to turn the conference over to Kellen Sanger, SOPHiA GENETICS Head of Strategy and Investor Relations. Please go ahead.
Kellen Sanger
Thank you, and good morning, everyone. Welcome to the SOPHiA GENETICS First Quarter 2025 Earnings Conference Call. Joining me today to discuss our results are Dr. Jurgi, our Co-Founder and Chief Executive Officer; Ross Muken, our company President; and George Cardoza, our Chief Financial Officer.
I’d like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated, and you should not place undue reliance on forward-looking statements.
Additional information regarding these risks, uncertainties, and factors that could cause results to differ appears in the press release issued by SOPHiA GENETICS today and in the documents and reports filed by SOPHiA GENETICS from time to time with the Securities and Exchange Commission. During this call, we will present both IFRS and non-IFRS financial measures. A reconciliation of IFRS to non-IFRS measures is included in today’s press release, which is available on our website.
With that, I’ll now turn the call over to Jurgi.
Jurgi Camblong
Thanks, Kellen, and
